Abstract
Glucagon may influence the exocrine pancreatic secretion stimulated by gastrointestinal hormones or by cholinergic drugs both in the conscious (1, 2, 3) and in the anaesthetized dogs (4, 5).
Cristalline glucagon probably about 90% pure. Contains about 10 of a component resembling mono-desamido glucagon which has nearly the same glycogenolytic potency as glucagon. Insulin content: 12 milliunits per mg or less.
We thank Dr. I. Slater from the Lilly Research Labs., Indianapolis (USA) for these informations and for the generous gift of glucagon.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Dyck W.P., Rudick J., Hoexta B., and Janowitz H.D.: Influence of glucagon on pancreatic exocrine secretion. Gastroenterology: 56, 531–537, 1969.
Nakajima S. and Nagee D.F.: Inhibition of exocrine pancreatic secretion by glucagon and D-glucose given intravenously. Can. J. Physiol. Pharmacol.: 48, 299–305, 1970.
Sweeting J.C.: The effect of glucagon on bile and pancreatic juice. Gastroenterology: 54, 1276, 1968.
Walker L. and Necheles H.: Effect of glucagon on pancreatic secretion. Amer. J. Physiol.: 187, 638, 1956.
Necheles H.: Effects of glucagon on external secretion of the pancreas. Amer. J. Physiol.: 191, 595–597, 1957.
Tibblin S., Kock N.S., and Shentz W.S.: Dissociation of the hyperglycemic and vascular effects of glucagon. Surgery: 67, 816–825, 1970.
Erspamer V.: Progress report: Caerulein. Gút: 11, 79–87, 1970.
Bertaccini G., De Caro G., and Melchiorri P.: The effects of caerulein on insulin secretion in anaesthetized dogs. Brit. J. Pharmac.: 40, 78–85, 1970.
De Caro G., Improta G., and Melchiorri P.: Effect of caerulein on glucagon secretion in the dog. Experientia: 26, 1145–1146, 1970.
Unger R.H., Ketter H., Duprè J., and Eisentrant A.M.: The effects of secretin, pancreozymin, and gastrin on insulin and glucagon secretion in anaesthetized dogs. J. Clin. Invest.: 46, 630–645, 1967.
Dorigotti L. and Glasser A.H.: Comparative effects of caerulein, pancreozymin, and secretin on pancreatic blood flow. Experientia: 24, 806–807, 1968.
Hoffman W.S.: A rapid photoelectric method for determination of glucose in blood and urine. J. Biol. Chem.: 120, 51–55, 1937.
Glasser A.H. and Dorigotti L.: Vasodilating action of caerulein and I.C.I. 50,123 on the canine pancreatic vascular bed. In “Pharmacology of Hormonal Polypeptides and Proteins”(Eds. Back W., Martini, L., and Paoletti R.) Plenum Press, New York, pp. 541–543, 1968.
Dorigotti L., Glasser A.H.: Relationhip between vasodilator and pancreatic stimulating properties of some caerulein-like peptides. In “Prostaglandins, Peptides and Amines” (Eds. Mante gazza P. and Horton E.W.) Academic Press, London, pp. 181–183, 1959.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1972 Plenum Press, New York
About this chapter
Cite this chapter
Glässer, A.G., Dorigotti, L., Vaghi, G. (1972). Inhibitory Activity of Glucagon on Caerulein Exocrine Stimulation, Independent of Hyperglycemia. In: Back, N., Sicuteri, F. (eds) Vasopeptides. Advances in Experimental Medicine and Biology, vol 21. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-7439-8_40
Download citation
DOI: https://doi.org/10.1007/978-1-4684-7439-8_40
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-7441-1
Online ISBN: 978-1-4684-7439-8
eBook Packages: Springer Book Archive